The global whole genome amplification market value is anticipated to cross US$ 5.5 Billion by the end of 2033, according to Future Market Insights (FMI) in its market analysis, as demand for WGA in forensics and the study of genetic disorders is on the rise.
Whole genome amplification sales are anticipated to reach US$ 2.8 Billion in 2023. Between 2023 and 2033, the market is anticipated to record a 7.0% CAGR.
Sample Report Copy: https://www.futuremarketinsights.com/reports/sample/rep-gb-6750
Due to its use in Forensics and Genetic Disorder Research, Demand Is Expected To Increase:
The adoption of whole-cell genome amplification as a powerful tool to help understand the ins and outs of genetics by bringing the entire genome structure to a cellular level act as the main factor driving the whole genome amplification market. WGA is increasingly being used for the examination of sequence information with optimized next generation whole-genome sequencing technologies with the help of a single cell.
The market for whole genome amplification is influenced by the use of this technique to provide a high-resolution picture of the genomic material and its use in numerous biological domains, including cancer research, tissue mosaicism, neuroscience, and immunology.
Restraint Factor for the Market From Growing:
The gene amplification technologies market is anticipated to see a slowdown because of the growing worries about the biassed and underrepresented loci PCR WGA that is causing a lack of trust in the method. The whole genome amplification market is expected to have difficulties throughout the forecast period due to the method’s revenue loss.
Market Positively Impacted By the Use of Single Cell WGA Kit:
The single-cell Whole Genome Amplification (WGA) is essential for bringing about new applications, and the market for WGA is positively impacted by the use of WGA in single-cell screening for a variety of genetic aBillionormalities affecting neurological development and growth.
The introduction of fresh procedures and the creation of cutting-edge tools have also created lucrative opportunities for the players in the market for whole genome amplification over the anticipated time frame.
Our Innovative Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-6750
Increasing Healthcare Infrastructure Penetration Of New Technologies And Installed Base:
The whole-cell genome amplification market also offers you in-depth market analyses for each country’s growth in capital equipment spending on healthcare, installed base of various gene amplification technologies market products, impact of technology using lifeline curves, and adjustments to healthcare regulatory scenarios and their effects on the market.
North American Outlook:
North America earned the most revenue, accounting for a considerable market share in the global market. This is due to the existence of multiple advanced healthcare facilities, huge growth in genetic testing, and ongoing research projects in the region.
The rising government investment in medical research and infrastructure is expected to promote the growth of the North American gene amplification technologies market.
Key Takeaways:
- The market for whole genome amplification in India is anticipated to grow to US$ 205.2 Million by 2033.
- The whole genome amplification market in China is anticipated to reach US$ 311.8 Million by 2033.
- By 2033, it is anticipated that the German market for whole genome amplification will bring in US$ 338.6 Million.
- The US market may expand at a CAGR of 6.7% over the projection year.
- During the forecast period, the CAGR for the Single Cell WGA Kit product type is predicted to be 7.1%.
- The UK market’s CAGR from 2023 to 2033 expected to reach around 9.2%.
- Over the forecast period, it is anticipated that the German market will grow at a CAGR of 8.9%.
- Between 2023 and 2033, the Indian whole genome amplification market is anticipated to grow at a CAGR of 8.2%.
- From 2023 to 2033, the whole genome amplification market in China is anticipated to expand at a CAGR of 9.1%.
- By 2033, it is predicted that the UK market for whole genome amplification would generate US$ 317 Million in revenue.
- By 2033, the US market is anticipated to grow to US$ 1.8 Billion.
- During the predicted year, the application category for agriculture and veterinary may experience growth at a CAGR of 6.8%.
Competitive Landscape:
The key vendors of the market are identified in this section of the report. Abbott Laboratories, Agilent Technologies, Inc., Ambion, Inc., Bio-Rad Laboratories, Danaher Corporation, Illumina Inc., Merck KGaA, Promega Corporation, QIAGEN N.V., Silicon Biosystems, Takara Bio, Inc., Vazyme Biotech Co. Ltd., and other prominent companies are listed among the report’s key players.
Recent Development:
- The life sciences division of GE Healthcare was purchased by the American corporation Danaher Corporation in April 2020. The company’s new name will be Cytvia. The change is anticipated to diversify the product line and increase the life sciences industry’s global footprint.
- In April 2021, Hologic acquired Mobidiag, a French-Finnish manufacturer of molecular tests, to satisfy the rising COVID-19 diagnostic demand.
- In order to strengthen its position as the industry leader in automated molecular testing, QIAGEN acquired NeuMoDx Molecular in 2020. NeuMoDx automation tools for medium and high-throughput PCR testing are now part of the QIAGEN range.
Request Purchase Now: https://www.futuremarketinsights.com/checkout/6750
Key Segments:
By Product Type:
- Single Cell WGA Kit
- Complete WGA Kit
- WGA Re-Amplification Kit
- WGA & Chip DNA Kit
- Others
By Application:
- Drug Discovery & Development
- Disease Diagnosis
- Agriculture & Veterinary
- Research
- Forensics
- Others
By End User:
- Pharma & Biotech Companies
- Hospitals & Clinics
- Contract Research
- Organizations
- Research & Academic Institutes
- Others
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia-Pacific excluding Japan (APEJ)
- Japan
- Middle East & Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube